相关实验视频

Updated: Jul 16, 2026

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries
08:49

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries

Published on: January 22, 2019

9.2K

胸腺瘤的代谢特征:潜在的生物标志物和治疗目标

James W Miller1, Brandon M Faubert2,3, Thomas P Mathews2

  • 1School of Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA.

European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery
|November 27, 2023
PubMed
概括

代谢学和13C-葡萄糖追踪在胸腺瘤中确定了独特的代谢生物标志物,将其与良性组织区分开来. 这些发现突出了改变的葡萄糖和乳酸代谢作为胸腺瘤的潜在治疗点.

关键词:
生物标志物 生物标志物代谢过程中的代谢.蒂莫马斯 (Thymomas) 是一种瘤.

更多相关视频

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice00:07

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

Published on: August 23, 2019

7.3K
Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies07:47

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies

Published on: September 15, 2023

1.5K

相关概念视频

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...